Gemifloxacin
Back to searchMolecule Structure
Scientific Name
Gemifloxacin
Description of the Drug
Gemifloxacin is a quinolone antibacterial agent used for the treatment of acute bacterial exacerbation of chronic bronchitis and mild to moderate community-acquired pneumonia caused by susceptible bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01155
http://www.drugbank.ca/drugs/DB01155
Brand Name(s)
Not Available
Company Owner(s)
Lg Chem Ltd, Orbion Pharmaceuticals Private Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363033 |
| DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311225 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL136633 | ||
| Human Metabolome Database | HMDB0015286 | ||
| DrugBank | DB01155 | ||
| PubChem: Thomson Pharma | 14878468 | ||
| PubChem | 9571107 | ||
| LINCS | LSM-44972 | ||
| Nikkaji | J726.319H | ||
| BindingDB | 50178917 | ||
| EPA CompTox Dashboard | DTXSID3048495 | ||
| DrugCentral | 1286 | ||
| ChemicalBook | CB3855593 | ||
| rxnorm | FACTIVE | GEMIFLOXACIN | GEMIFLOXACIN MESYLATE |
| ChEBI | 101853 |
